Astellas Pharma (ALPMY) Earnings Date & Reports

Astellas Pharma Inc is a specialty global pharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ALPMY is expected to report earnings to fall 137.63% to 13 cents per share on April 24

Astellas Pharma ALPMY Stock Earnings Reports

Q1'25

Est.

$0.13

Q4'24

Missed

by $0.41

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.08

Q1'24

Missed

by $0.10

The last earnings report on February 04 showed earnings per share of -35 cents, missing the estimate of 5 cents. With 110.80K shares outstanding, the current market capitalization sits at 26.55B.

View a ticker or compare two or three

Compare

ALPMY

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ALPMY
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry PharmaceuticalsMajor

Profile

Fundamentals

Details

Industry

N/A

Address

2-5-1, Nihonbashi-Honcho

Phone

+81 332443000

Employees

16243

Web

http://www.astellas.com